New insights into the functions and localization of nuclear transglutaminase 2

FEBS Journal

Volumn 278, Issue 24, 2011, Pages 4756-4767

  Kuo, Ting Fang ^a,b   Tatsukawa, Hideki ^a   Kojima, Soichi ^a,b  

^a RIKEN   (Japan)

^b TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

exportin; importin; nuclear localization; nuclear TG2; regulation of gene expression

Indexed keywords

AMIDASE; AMIDOTRANSFERASE; CALCIUM ION; COFILIN; CYSTAMINE; DANSYLCADAVERINE; FIBRONECTIN; GUANOSINE TRIPHOSPHATASE; HISTONE; HISTONE H2A; HISTONE H2B; HISTONE H3; HISTONE H4; HUNTINGTIN; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; INTEGRIN; LAMIN; PROTEIN C FOS; PROTEIN C JUN; PROTEIN DISULFIDE ISOMERASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; PROTEIN KINASE; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; APOPTOSIS; CALCIUM CELL LEVEL; CELL ADHESION; CELL DIFFERENTIATION; CELL GROWTH; CELL HYPOXIA; CELL MEMBRANE; CELL NUCLEUS; CELL NUCLEUS INCLUSION BODY; CELL STRESS; CELL SURVIVAL; CELLULAR DISTRIBUTION; CYTOPLASM; CYTOSOL; DEGENERATIVE DISEASE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME SUBSTRATE; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HUMAN; HUNTINGTON CHOREA; LIVER DISEASE; MALIGNANT NEOPLASTIC DISEASE; MITOCHONDRION; MOLECULAR MECHANICS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN TRANSPORT; REVIEW; STIMULUS RESPONSE;

ANIMALS; ANOXIA; CELL DIFFERENTIATION; CELL NUCLEUS; E2F1 TRANSCRIPTION FACTOR; EXTRACELLULAR MATRIX; FATTY LIVER; FATTY LIVER, ALCOHOLIC; GTP-BINDING PROTEINS; HISTONES; HUMANS; HUNTINGTON DISEASE; NUCLEAR LOCALIZATION SIGNALS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RETINOBLASTOMA PROTEIN; SP1 TRANSCRIPTION FACTOR; TRANSGLUTAMINASES;

EID: 82755187316     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2011.08409.x     Document Type: Review

References (93)

1. 2+-dependent action of a multifunctional protein. FEBS J 278, 4717-4739.
2. Walther D, Stahlberg S, &, Vowinckel J, (2011) Novel roles for primeval chemicals: from monoamines in transglutaminase-mediated posttranslational protein modification to monoaminylation deregulation diseases. FEBS J 278, 4740-4755.
3. Fesus L, &, Piacentini M, (2002) Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem Sci 27, 534-539. (Pubitemid 35279599)
4. Belkin A, (2011) Extracellular TG2: the emerging functions and regulation. FEBS J 278, 4704-4716.
5. Birckbichler PJ, Orr GR, &, Patterson MK Jr, (1976) Differential transglutaminase distribution in normal rat liver and rat hepatoma. Cancer Res 36, 2911-2914.
6. Griffin M, Barnes RN, Wynne J, &, Williams C, (1978) The effects of bleomycin and copper bleomycin upon transglutaminase enzymes. Biochem Pharmacol 27, 1211-1219. (Pubitemid 8393262)
7. Clarke DD, Mycek MJ, Neidle A, &, Waelsch H, (1959) The incorporation of amines into protein. Arch Biochem Biophys 79, 338-354.
8. Haddox MK, &, Russell DH, (1981) Increased nuclear conjugated polyamines and transglutaminase during liver regeneration. Proc Natl Acad Sci USA 78, 1712-1716.
9. Bruce SE, &, Peters TJ, (1983) The subcellular localization of transglutaminase in normal liver and in glucagon-treated and partial hepatectomized rats. Biosci Rep 3, 1085-1090. (Pubitemid 14157462)
10. Singh US, Erickson JW, &, Cerione RA, (1995) Identification and biochemical characterization of an 80 kilodalton GTP-binding/transglutaminase from rabbit liver nuclei. Biochemistry 34, 15863-15871.
11. Lesort M, Attanavanich K, Zhang J, &, Johnson G, (1998) Distinct nuclear localization and activity of tissue transglutaminase. J Biol Chem 273, 11991-11994. (Pubitemid 28240553)
12. Shimizu T, Hozumi K, Horiike S, Nunomura K, Ikegami S, Takao T, &, Shimonishi Y, (1996) A covalently crosslinked histone. Nature 380, 32.
13. Shimizu T, Takao T, Hozumi K, Nunomura K, Ohta S, Shimonishi Y, &, Ikegami S, (1997) Structure of a covalently cross-linked form of core histones present in the starfish sperm. Biochemistry 36, 12071-12079. (Pubitemid 27440945)
14. Ballestar E, Abad C, &, Franco L, (1996) Core histones are glutaminyl substrates for tissue transglutaminase. J Biol Chem 271, 18817-18824. (Pubitemid 26322752)
15. Mishra S, Saleh A, Espino PS, Davie JR, &, Murphy LJ, (2006) Phosphorylation of histones by tissue transglutaminase. J Biol Chem 281, 5532-5538. (Pubitemid 43847648)
16. Weintraub SJ, Chow KN, Luo RX, Zhang SH, He S, &, Dean DC, (1995) Mechanism of active transcriptional repression by the retinoblastoma protein. Nature 375, 812-815.
17. Oliverio S, Amendola A, Di Sano F, Farrace MG, Fesus L, Nemes Z, Piredda L, Spinedi A, &, Piacentini M, (1997) Tissue transglutaminase-dependent posttranslational modification of the retinoblastoma gene product in promonocytic cells undergoing apoptosis. Mol Cell Biol 17, 6040-6048. (Pubitemid 27411112)
18. Boehm JE, Singh U, Combs C, Antonyak MA, &, Cerione RA, (2002) Tissue transglutaminase protects against apoptosis by modifying the tumor suppressor protein p110 Rb. J Biol Chem 277, 20127-20130. (Pubitemid 34967301)
19. Milakovic T, Tucholski J, McCoy E, &, Johnson GV, (2004) Intracellular localization and activity state of tissue transglutaminase differentially impacts cell death. J Biol Chem 279, 8715-8722. (Pubitemid 38295927)
20. Mishra S, Melino G, &, Murphy LJ, (2007) Transglutaminase 2 kinase activity facilitates protein kinase A-induced phosphorylation of retinoblastoma protein. J Biol Chem 282, 18108-18115. (Pubitemid 47100203)
21. Balajthy Z, Csomos K, Vamosi G, Szanto A, Lanotte M, &, Fesus L, (2006) Tissue-transglutaminase contributes to neutrophil granulocyte differentiation and functions. Blood 108, 2045-2054. (Pubitemid 44395020)
22. Csomos K, Nemet I, Fesus L, &, Balajthy Z, (2010) Tissue transglutaminase contributes to the all-trans-retinoic acid-induced differentiation syndrome phenotype in the NB4 model of acute promyelocytic leukemia. Blood 116, 3933-3943.
23. Filiano AJ, Bailey CD, Tucholski J, Gundemir S, &, Johnson GV, (2008) Transglutaminase 2 protects against ischemic insult, interacts with HIF1β, and attenuates HIF1 signaling. FASEB J 22, 2662-2675.
24. Filiano AJ, Tucholski J, Dolan PJ, Colak G, &, Johnson GV, (2010) Transglutaminase 2 protects against ischemic stroke. Neurobiol Dis 39, 334-343.
25. Mastroberardino PG, Iannicola C, Nardacci R, Bernassola F, De Laurenzi V, Melino G, Moreno S, Pavone F, Oliverio S, Fesus L, et al. (2002) 'Tissue' transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease. Cell Death Differ 9, 873-880. (Pubitemid 35023603)
26. Gundemir S, &, Johnson GV, (2009) Intracellular localization and conformational state of transglutaminase 2: implications for cell death. PLoS ONE 4, e6123.
27. Boyd JM, Malstrom S, Subramanian T, Venkatesh LK, Schaeper U, Elangovan B, D'Sa-Eipper C, &, Chinnadurai G, (1994) Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell 79, 341-351. (Pubitemid 24324923)
28. Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, Tokino T, Taniguchi T, &, Tanaka N, (2000) Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288, 1053-1058. (Pubitemid 30324238)
29. D'Souza DR, Wei J, Shao Q, Hebert MD, Subramony SH, &, Vig PJ, (2006) Tissue transglutaminase crosslinks ataxin-1: possible role in SCA1 pathogenesis. Neurosci Lett 409, 5-9. (Pubitemid 44585111)
30. Karpuj MV, Garren H, Slunt H, Price DL, Gusella J, Becher MW, &, Steinman L, (1999) Transglutaminase aggregates huntingtin into nonamyloidogenic polymers, and its enzymatic activity increases in Huntington's disease brain nuclei. Proc Natl Acad Sci USA 96, 7388-7393. (Pubitemid 29299671)
31. Zhai W, Jeong H, Cui L, Krainc D, &, Tjian R, (2005) In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple transcription factor targets. Cell 123, 1241-1253. (Pubitemid 41821782)
32. Martin A, De Vivo G, &, Gentile V, (2011) Possible role of the transglutaminases in the pathogenesis of Alzheimer's disease and other neurodegenerative diseases. Int J Alzheimers Dis 2011, 865432.
33. Junn E, Ronchetti RD, Quezado MM, Kim SY, &, Mouradian MM, (2003) Tissue transglutaminase-induced aggregation of α-synuclein: implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 100, 2047-2052. (Pubitemid 36254571)
34. Kahlem P, Green H, &, Djian P, (1998) Transglutaminase action imitates Huntington's disease: selective polymerization of Huntingtin containing expanded polyglutamine. Mol Cell 1, 595-601. (Pubitemid 128374695)
35. Miller ML, &, Johnson GV, (1995) Transglutaminase cross-linking of the tau protein. J Neurochem 65, 1760-1770.
36. Murthy SN, Wilson JH, Lukas TJ, Kuret J, &, Lorand L, (1998) Cross-linking sites of the human tau protein, probed by reactions with human transglutaminase. J Neurochem 71, 2607-2614. (Pubitemid 28531274)
37. Ikura K, Takahata K, &, Sasaki R, (1993) Cross-linking of a synthetic partial-length (1-28) peptide of the Alzheimer β/A4 amyloid protein by transglutaminase. FEBS Lett 326, 109-111. (Pubitemid 23200258)
38. Dudek SM, &, Johnson GV, (1994) Transglutaminase facilitates the formation of polymers of the β-amyloid peptide. Brain Res 651, 129-133. (Pubitemid 24222858)
39. Zainelli GM, Ross CA, Troncoso JC, &, Muma NA, (2003) Transglutaminase cross-links in intranuclear inclusions in Huntington disease. J Neuropathol Exp Neurol 62, 14-24. (Pubitemid 36068889)
40. Igarashi S, Koide R, Shimohata T, Yamada M, Hayashi Y, Takano H, Date H, Oyake M, Sato T, Sato A, et al. (1998) Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch. Nat Genet 18, 111-117. (Pubitemid 28082456)
41. Bailey CD, &, Johnson GV, (2005) Tissue transglutaminase contributes to disease progression in the R6/2 Huntington's disease mouse model via aggregate-independent mechanisms. J Neurochem 92, 83-92. (Pubitemid 40193511)
42. D'Eletto M, Farrace MG, Falasca L, Reali V, Oliverio S, Melino G, Griffin M, Fimia GM, &, Piacentini M, (2009) Transglutaminase 2 is involved in autophagosome maturation. Autophagy 5, 1145-1154.
43. Lesort M, Lee M, Tucholski J, &, Johnson GV, (2003) Cystamine inhibits caspase activity. Implications for the treatment of polyglutamine disorders. J Biol Chem 278, 3825-3830. (Pubitemid 36801110)
44. Ientile R, Campisi A, Raciti G, Caccamo D, Curro M, Cannavo G, Li Volti G, Macaione S, &, Vanella A, (2003) Cystamine inhibits transglutaminase and caspase-3 cleavage in glutamate-exposed astroglial cells. J Neurosci Res 74, 52-59. (Pubitemid 37176666)
45. Mastroberardino PG, &, Piacentini M, (2010) Type 2 transglutaminase in Huntington's disease: a double-edged sword with clinical potential. J Intern Med 268, 419-431.
46. McConoughey SJ, Basso M, Niatsetskaya ZV, Sleiman SF, Smirnova NA, Langley BC, Mahishi L, Cooper AJ, Antonyak MA, Cerione RA, et al. (2010) Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease. EMBO Mol Med 2, 349-370.
47. Colby DW, Cassady JP, Lin GC, Ingram VM, &, Wittrup KD, (2006) Stochastic kinetics of intracellular huntingtin aggregate formation. Nat Chem Biol 2, 319-323. (Pubitemid 43787213)
48. Munsie L, Caron N, Atwal RS, Marsden I, Wild EJ, Bamburg JR, Tabrizi SJ, &, Truant R, (2011) Mutant huntingtin causes defective actin remodeling during stress: defining a new role for transglutaminase 2 in neurodegenerative disease. Hum Mol Genet 20, 1937-1951.
49. McGough A, Pope B, Chiu W, &, Weeds A, (1997) Cofilin changes the twist of F-actin: implications for actin filament dynamics and cellular function. J Cell Biol 138, 771-781. (Pubitemid 27365041)
50. Akimov SS, &, Belkin AM, (2001) Cell-surface transglutaminase promotes fibronectin assembly via interaction with the gelatin-binding domain of fibronectin: a role in TGF β-dependent matrix deposition. J Cell Sci 114, 2989-3000. (Pubitemid 32821537)
51. Gaudry CA, Verderio E, Aeschlimann D, Cox A, Smith C, &, Griffin M, (1999) Cell surface localization of tissue transglutaminase is dependent on a fibronectin-binding site in its N-terminal β-sandwich domain. J Biol Chem 274, 30707-30714.
52. Dunah AW, Jeong H, Griffin A, Kim YM, Standaert DG, Hersch SM, Mouradian MM, Young AB, Tanese N, &, Krainc D, (2002) Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science 296, 2238-2243. (Pubitemid 34680312)
53. Li SH, Cheng AL, Zhou H, Lam S, Rao M, Li H, &, Li XJ, (2002) Interaction of Huntington disease protein with transcriptional activator Sp1. Mol Cell Biol 22, 1277-1287. (Pubitemid 34150765)
54. Chen-Plotkin AS, Sadri-Vakili G, Yohrling GJ, Braveman MW, Benn CL, Glajch KE, DiRocco DP, Farrell LA, Krainc D, Gines S, et al. (2006) Decreased association of the transcription factor Sp1 with genes downregulated in Huntington's disease. Neurobiol Dis 22, 233-241.
55. Zuccato C, Ciammola A, Rigamonti D, Leavitt BR, Goffredo D, Conti L, MacDonald ME, Friedlander RM, Silani V, Hayden MR, et al. (2001) Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science 293, 493-498. (Pubitemid 32679077)
56. Irrcher I, &, Hood DA, (2004) Regulation of Egr-1, SRF, and Sp1 mRNA expression in contracting skeletal muscle cells. J Appl Physiol 97, 2207-2213. (Pubitemid 39552461)
57. Evans MJ, &, Scarpulla RC, (1989) Interaction of nuclear factors with multiple sites in the somatic cytochrome c promoter. Characterization of upstream NRF-1, ATF, and intron Sp1 recognition sequences. J Biol Chem 264, 14361-14368. (Pubitemid 19214267)
58. Connor MK, Irrcher I, &, Hood DA, (2001) Contractile activity-induced transcriptional activation of cytochrome C involves Sp1 and is proportional to mitochondrial ATP synthesis in C2C12 muscle cells. J Biol Chem 276, 15898-15904.
59. Kazemi-Esfarjani P, &, La Spada AR, (2010) Déjà vu with a twist: transglutaminases in bioenergetics and transcriptional dysfunction in Huntington's disease. EMBO Mol Med 2, 335-337.
60. Courey AJ, Holtzman DA, Jackson SP, &, Tjian R, (1989) Synergistic activation by the glutamine-rich domains of human transcription factor Sp1. Cell 59, 827-836. (Pubitemid 20022373)
61. Han JA, &, Park SC, (2000) Transglutaminase-dependent modulation of transcription factor Sp1 activity. Mol Cells 10, 612-618.
62. Tatsukawa H, &, Kojima S, (2010) Recent advances in understanding the roles of transglutaminase 2 in alcoholic steatohepatitis. Cell Biol Int 34, 325-334.
63. Tatsukawa H, Fukaya Y, Frampton G, Martinez-Fuentes A, Suzuki K, Kuo TF, Nagatsuma K, Shimokado K, Okuno M, Wu J, et al. (2009) Role of transglutaminase 2 in liver injury via cross-linking and silencing of transcription factor Sp1. Gastroenterology 136, 1783-1795.
64. Kuo TF, Tatsukawa H, Matsuura T, Nagatsuma K, Hirose S, &, Kojima S, (2011) Free fatty acids induce transglutaminase 2-dependent apoptosis in hepatocytes via ER stress-stimulated PERK pathways. J Cell Physiol doi:.
65. Pascal E, &, Tjian R, (1991) Different activation domains of Sp1 govern formation of multimers and mediate transcriptional synergism. Genes Dev 5, 1646-1656. (Pubitemid 21906069)
66. Shimada J, Suzuki Y, Kim SJ, Wang PC, Matsumura M, &, Kojima S, (2001) Transactivation via RAR/RXR-Sp1 interaction: characterization of binding between Sp1 and GC box motif. Mol Endocrinol 15, 1677-1692. (Pubitemid 32939299)
67. Tatsukawa H, Sano T, Fukaya Y, Ishibashi N, Watanabe M, Okuno M, Moriwaki H, &, Kojima S, (2011) Dual induction of caspase 3- and transglutaminase-dependent apoptosis by acyclic retinoid in hepatocellular carcinoma cells. Mol Cancer 10, 4.
68. Ahn JS, Kim MK, Hahn JH, Park JH, Park KH, Cho BR, Park SB, &, Kim DJ, (2008) Tissue transglutaminase-induced down-regulation of matrix metalloproteinase-9. Biochem Biophys Res Commun 376, 743-747.
69. Mandrusiak LM, Beitel LK, Wang X, Scanlon TC, Chevalier-Larsen E, Merry DE, &, Trifiro MA, (2003) Transglutaminase potentiates ligand-dependent proteasome dysfunction induced by polyglutamine-expanded androgen receptor. Hum Mol Genet 12, 1497-1506. (Pubitemid 36857298)
70. Glass WF II, Briggs JA, Meredith MJ, Briggs RC, &, Hnilica LS, (1985) Enzymatic modification of Novikoff hepatoma lamins A and C. J Biol Chem 260, 1895-1900. (Pubitemid 15144802)
71. Kazerounian S, &, Aho S, (2003) Characterization of periphilin, a widespread, highly insoluble nuclear protein and potential constituent of the keratinocyte cornified envelope. J Biol Chem 278, 36707-36717. (Pubitemid 37140003)
72. Orru S, Caputo I, D'Amato A, Ruoppolo M, &, Esposito C, (2003) Proteomics identification of acyl-acceptor and acyl-donor substrates for transglutaminase in a human intestinal epithelial cell line. Implications for celiac disease. J Biol Chem 278, 31766-31773. (Pubitemid 37048357)
73. Keresztessy Z, Csosz E, Harsfalvi J, Csomos K, Gray J, Lightowlers RN, Lakey JH, Balajthy Z, &, Fesus L, (2006) Phage display selection of efficient glutamine-donor substrate peptides for transglutaminase 2. Protein Sci 15, 2466-2480. (Pubitemid 44771684)
74. Facchiano A, &, Facchiano F, (2009) Transglutaminases and their substrates in biology and human diseases: 50 years of growing. Amino Acids 36, 599-614.
75. Mann AP, Verma A, Sethi G, Manavathi B, Wang H, Fok JY, Kunnumakkara AB, Kumar R, Aggarwal BB, &, Mehta K, (2006) Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-κB in cancer cells: delineation of a novel pathway. Cancer Res 66, 8788-8795. (Pubitemid 44449196)
76. Takeuchi Y, Ohashi H, Birckbichler PJ, &, Ikejima T, (1998) Nuclear translocation of tissue type transglutaminase during sphingosine-induced cell death: a novel aspect of the enzyme with DNA hydrolytic activity. Z Naturforsch C 53, 352-358. (Pubitemid 28320375)
77. Campisi A, Caccamo D, Raciti G, Cannavo G, Macaione V, Curro M, Macaione S, Vanella A, &, Ientile R, (2003) Glutamate-induced increases in transglutaminase activity in primary cultures of astroglial cells. Brain Res 978, 24-30. (Pubitemid 36776621)
78. Peng X, Zhang Y, Zhang H, Graner S, Williams JF, Levitt ML, &, Lokshin A, (1999) Interaction of tissue transglutaminase with nuclear transport protein importin- α3. FEBS Lett 446, 35-39. (Pubitemid 29127245)
79. Greenspan D, Palese P, &, Krystal M, (1988) Two nuclear location signals in the influenza virus NS1 nonstructural protein. J Virol 62, 3020-3026.
80. Chaturvedi MM, Sung B, Yadav VR, Kannappan R, &, Aggarwal BB, (2011) NF-κB addiction and its role in cancer: 'one size does not fit all'. Oncogene 30, 1615-1630.
81. Verma A, &, Mehta K, (2007) Transglutaminase-mediated activation of nuclear transcription factor-κB in cancer cells: a new therapeutic opportunity. Curr Cancer Drug Targets 7, 559-565. (Pubitemid 47358142)
82. Lee J, Kim YS, Choi DH, Bang MS, Han TR, Joh TH, &, Kim SY, (2004) Transglutaminase 2 induces nuclear factor-κB activation via a novel pathway in BV-2 microglia. J Biol Chem 279, 53725-53735. (Pubitemid 40051881)
83. Dardik R, &, Inbal A, (2006) Complex formation between tissue transglutaminase II (tTG) and vascular endothelial growth factor receptor 2 (VEGFR-2): proposed mechanism for modulation of endothelial cell response to VEGF. Exp Cell Res 312, 2973-2982. (Pubitemid 44292656)
84. Mehul B, Bawumia S, &, Hughes RC, (1995) Cross-linking of galectin 3, a galactose-binding protein of mammalian cells, by tissue-type transglutaminase. FEBS Lett 360, 160-164.
85. Singh US, Li Q, &, Cerione R, (1998) Identification of the eukaryotic initiation factor 5A as a retinoic acid-stimulated cellular binding partner for tissue transglutaminase II. J Biol Chem 273, 1946-1950. (Pubitemid 28069238)
86. Amendola A, Rodolfo C, Di Caro A, Ciccosanti F, Falasca L, &, Piacentini M, (2001) 'Tissue' transglutaminase expression in HIV-infected cells: an enzyme with an antiviral effect? Ann N Y Acad Sci 946, 108-120. (Pubitemid 33127212)
87. Jao DL, &, Yu Chen K, (2002) Subcellular localization of the hypusine-containing eukaryotic initiation factor 5A by immunofluorescent staining and green fluorescent protein tagging. J Cell Biochem 86, 590-600. (Pubitemid 36076175)
88. Lebska M, Ciesielski A, Szymona L, Godecka L, Lewandowska-Gnatowska E, Szczegielniak J, &, Muszynska G, (2010) Phosphorylation of maize eukaryotic translation initiation factor 5A (eIF5A) by casein kinase 2: identification of phosphorylated residue and influence on intracellular localization of eIF5A. J Biol Chem 285, 6217-6226.
89. Fornerod M, Ohno M, Yoshida M, &, Mattaj IW, (1997) CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 90, 1051-1060. (Pubitemid 27408519)
90. Haasen D, Kohler C, Neuhaus G, &, Merkle T, (1999) Nuclear export of proteins in plants: AtXPO1 is the export receptor for leucine-rich nuclear export signals in Arabidopsis thaliana. Plant J 20, 695-705.
91. Stade K, Ford CS, Guthrie C, &, Weis K, (1997) Exportin 1 (Crm1p) is an essential nuclear export factor. Cell 90, 1041-1050. (Pubitemid 27408518)
92. la Cour T, Kiemer L, Molgaard A, Gupta R, Skriver K, &, Brunak S, (2004) Analysis and prediction of leucine-rich nuclear export signals. Protein Eng Des Sel 17, 527-536. (Pubitemid 39487532)
93. Montgomery SA, &, Johnston RE, (2007) Nuclear import and export of Venezuelan equine encephalitis virus nonstructural protein 2. J Virol 81, 10268-10279. (Pubitemid 47463302)